Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12916-017-0786-8
PubMed Identifier: 28173834
Publication URI: http://europepmc.org/abstract/MED/28173834
Type: Journal Article/Review
Volume: 15
Parent Publication: BMC medicine
Issue: 1
ISSN: 1741-7015